Strategy

Bern, Switzerland-based AI startup (founded 2019) focused on AI-driven clinical trial protocol authoring and optimization, with academic ties to the University of Bern. Positioned as a narrow but deep specialist in protocol design backed by a large clinical-trial knowledge graph.

Key Products

• Protocol AI™ — End-to-end NLP/ML solution for designing and optimizing clinical trial protocols, powered by a database of 800,000+ clinical trials linked to publications, regulatory approvals, and safety data

Services

• Protocol design consulting
• Integration support for EDC/eTMF systems

Target Customers

Biopharma and medical device sponsors (small to large), CROs

Notable Positioning

Deepest specialization in AI-driven clinical trial protocol authoring, with a publicly announced Citeline partnership for protocol design and optimization.

Strategy

AI-native regulatory automation platform covering the full submission lifecycle (IND through NDA/BLA and post-market), positioning as a partner-augmented alternative to incumbent RIM systems for biotechs and CROs.

Key Products

• Weave Platform — AI-native regulatory content platform covering IND and NDA submission workflows, with data extraction, authoring, verification, and lifecycle management
• Submission Builder — eCTD-formatted templates and submission assembly
• HAQ Manager — Health Authority query/response management

Services

• Regulatory implementation support via Parexel partnership

Target Customers

Pharma, biotech, CROs, and regulatory consultants (Top 20 pharma companies cited as users on website)

Notable Positioning

AI-native platform spanning IND through NDA submission workflows plus HAQ responses; full lifecycle coverage in roll-out. Backed by $20M Series A (announced Oct 2025) and an NDA Workflow co-designed with Parexel (announced Apr 2026).

Strategy

Microsoft-cloud-based componentized intelligent content platform for regulated life sciences, focused on structured component authoring, content reuse, and governance with GenAI-assisted authoring inside Microsoft Word.

Key Products

• InteliNotion Platform — GenAI-assisted structured content authoring, component management and content governance for medical/regulatory writing, with a native Microsoft Word add-in for real-time co-authoring

Services

Pure-product company — no explicit services listed

Target Customers

Life sciences medical writing and regulatory affairs teams (mid-to-large pharma)

Notable Positioning

Positioned as a successor to legacy CCMS (Component Content Management Systems), purpose-built for life sciences with deep MS Word UX, rather than a one-shot AI generator.

Strategy

AI-powered structured content authoring platform for life sciences, emphasizing component reuse (CCMS) governance and modular content across regulatory, clinical, labeling, CMC and safety functions.

Key Products

• Docuvera Platform — Structured component authoring + GenAI first-draft creation with metadata governance and reuse; supports eCTD 4.0, KASA, ICH M11, USDM, FDA SPL/ePI and HL7 FHIR
• Chemistry, Manufacturing & Controls (CMC) — Structured CMC content authoring
• Clinical Documentation — Protocols, CSRs, IBs with reusable modular components
• Global Labeling — CCDS, SmPC, USPI labeling content management
• Medical Information — Component-based authoring for global medical information content

Services

• Content modeling and migration consulting

Target Customers

Large pharma adopters such as Eli Lilly and Boehringer Ingelheim; mid-to-large life sciences organizations

Notable Positioning

Production-proven structured-content reuse at Eli Lilly (65% component reuse in Global Medical Information in the first year, per Docuvera case study), differentiating on governance and inspection-readiness rather than AI generation alone.

Strategy

YC-backed (W24) GenAI medical writing platform founded 2023 in San Francisco, that turns sponsor data into draft regulatory submissions in minutes, targeting lean biotech and device teams with template-aware AI assistants per document type.

Key Products

• Artos Platform — GenAI drafting engine that connects to sponsor data sources and templates to produce regulatory document drafts
• Document AI Agents — Per-document-type AI systems (IND, IB, CSR, CMC, nonclinical, clinical) trained to fit company templates
• Veeva RIM / Box Integrations — Native connectors into existing DMS tools so drafts flow back into the system of record

Services

• Template configuration and onboarding

Target Customers

Small to mid-size biotech and medical device companies

Notable Positioning

YC startup explicitly marketing across IND/NDA/BLA/PMA scope and offering a per-doc-type AI agent design that adapts to each sponsor's existing template library.

Strategy

Agentic AI / NLG platform for life sciences specializing in high-volume generation of clinical study reports, patient narratives and other regulatory documents from structured trial data.

Key Products

• Narrativa® Agentic AI Platform — Agent-based regulatory and commercialization content generation platform with AI agents, knowledge graph, security/privacy, compliance and infrastructure layers

Services

• Custom NLG model implementation
• Document automation managed services

Target Customers

Pharma sponsors and CROs needing high-volume CSR and narrative output (Pfizer, Santen, Almirall, Asphalion, Blood Cancer United cited as customers)

Notable Positioning

NLG specialist focused on agentic AI for life sciences, with depth in CSR and patient narrative automation across regulatory and commercialization workflows.

Strategy

Metadata repository (MDR) and clinical data standards platform enabling digitalized clinical development, focused on CDISC/SDTM standards management rather than narrative authoring.

Key Products

• Nurocor Clinical Platform — AI-native platform for clinical development with end-to-end clinical standards traceability; supports ICH M11, USDM and CDISC standards
• Nurocor Lean Protocol™ — ICH M11-compliant protocol authoring with AI-aligned CDISC standards
• Nurocor Digital Asset Repository — Metadata and asset repository underpinning clinical standards governance
• Nurocor Controlled Terminology Importer — Manages CDISC controlled terminology quarterly releases and change impact

Services

• Standards governance advisory and implementation services

Target Customers

Biopharma R&D data standards and biometrics teams

Notable Positioning

Not a writing tool — adjacent infrastructure play focused on CDISC metadata governance that feeds downstream SDTM submission packages.

Strategy

Regulatory-grade AI for life sciences using neuro-symbolic AI to deliver compliant, traceable medical writing automation across clinical, safety, preclinical and CMC workflows. Yseop Copilot was named to TIME's Best Inventions 2025 (Medical & Healthcare).

Key Products

• Yseop Copilot — Structured platform automating regulated content in MS Word and Veeva Vault, with automation packs per document type
• Clinical Automation Pack — CSR, CTN, SCS/SCE, IB, ICF automated drafting
• Preclinical Automation Pack — Pharmacokinetics and preclinical study report automation
• CMC Automation Pack — Module 3 / CMC documentation automation (newly expanded)

Services

• Automation pack configuration
• Validation and compliance support

Target Customers

Large pharma (GSK, Eli Lilly, Sanofi cited as customers) and mid-size biopharma with mature medical writing functions

Notable Positioning

Differentiates on neuro-symbolic AI for regulatory-grade traceability; less than 7% of generated content requires re-authoring on the GSK CSR benchmark — accuracy/traceability story rather than raw LLM generation.

Strategy

Singapore-based, China-focused AI services + platform combining AI document writing with regulatory translation, eCTD submission, statistics and data management — services-heavy GTM serving global pharma operating in Asia.

Key Products

• AI R&D Writing — Auto-drafting of CSRs, protocols, IBs and other regulatory documents
• Intelligent Regulatory Translation — High-volume multilingual translation of regulatory documents (EN/ZH and others)
• eCTD Submission Platform — Streamlined eCTD assembly and submission tooling

Services

• Regulatory writing as a service
• Statistical analysis
• Clinical data management
• Medical translation

Target Customers

Global pharma operating in Asia and Chinese biotechs out-licensing globally; CROs and regulatory teams

Notable Positioning

Singapore-headquartered; only player in this set with deep China/Asia regulatory expertise and a sizeable services bench (51–200 employees per LinkedIn), pitching ~40% lower cost and faster execution on out-licensing dossiers.

Strategy

Established cloud SaaS incumbent consolidating R&D and commercial systems for life sciences. Vault RIM is the de facto enterprise system of record for regulatory information, with an AI partner ecosystem extending authoring capabilities.

Key Products

• Vault Submissions — Authoring, review, approval and assembly of clinical, CMC, nonclinical, summaries and labeling content
• Vault Submissions Publishing — End-to-end eCTD / regional eSub publishing and Health Authority output generation
• Vault Registrations — Product registration tracking, HA correspondence/commitments, IDMP messaging
• Vault Submissions Archive — Global archive of previously published submissions
• Vault MedComms / Medical — Medical communications content management

Services

• Veeva Business Consulting
• Implementation and validation services
• Veeva AI Partner Program

Target Customers

Top 50 pharma and biotech, mid-size sponsors globally; widely adopted across major life sciences enterprises (per Veeva customer announcements)

Notable Positioning

Industry-standard system of record for regulatory content — competes on platform breadth and ecosystem. Veeva AI Partner Program publicly lists partners including ZS, TransPerfect, Adobe, MMIT, ACTO and others.

Strategy

Global management consulting and analytics firm for life sciences, blending strategy/operations consulting with the ZAIDYN technology platform; in regulatory it pitches GenAI-enabled regulatory intelligence rather than a packaged writing product.

Key Products

• ZAIDYN Platform — Cloud-native life sciences analytics and engagement platform spanning commercial and R&D
• Regulatory Intelligence (GenAI) — AI-enabled tooling to compare requirements across markets, track HA queries and predict future questions

Services

• R&D and regulatory strategy consulting
• Medical affairs and evidence consulting
• GenAI / analytics implementation
• Commercial and operations consulting

Target Customers

Top 20 pharma and large biotech (enterprise consulting buyers)

Notable Positioning

Consulting-led play — strongest at strategic regulatory intelligence and decision support, not packaged document authoring; named the highest-designated Leader in the 2025 Everest Group Life Sciences AI and Analytics Services PEAK Matrix®. Also a Veeva AI Partner Program member.

Strategy

Biosimulation and drug development software incumbent (NASDAQ: CERT) expanding into AI-powered regulatory writing and submissions; combines technology (CoAuthor™, Pinnacle 21®, GlobalSubmit™) with deep regulatory writing services. Cited on certara.com as supporting 90%+ of FDA novel drug approvals from 2014–2025 and 8,000+ customer projects in the last decade.

Key Products

• CoAuthor — GenAI regulatory writing software in MS Word with eCTD template library and biomedical GPT
• Pinnacle 21 Enterprise — CDISC / SDTM / ADaM data validation and submission readiness
• GlobalSubmit — eCTD publishing, validation and reviewer software
• Certara.AI — AI platform applied across biosimulation, regulatory and medical writing

Services

• Regulatory writing services (clinical, CMC, nonclinical)
• Regulatory submissions services (IND/IMPD, NDA/BLA, briefing docs)
• Drug development and biosimulation consulting

Target Customers

Top 50 pharma, biotech of all sizes; 2,600+ companies trust Certara software (per certara.com)

Notable Positioning

One of the few vendors combining GenAI authoring (CoAuthor™), data-standards validation (Pinnacle 21®) and eCTD publishing (GlobalSubmit™) in a single portfolio.

Strategy

AI-augmented regulatory services firm (founded 2017, headquartered in Downers Grove, IL near Chicago, with offices in Bengaluru, London, Netherlands and Romania) that pairs human medical writers with its CAPTIS platform to deliver CER, CSR, CTD and CMC authoring for pharma, medical device and IVD manufacturers. GTM thesis: 'tech-empowered' outsourced regulatory writing — cheaper and faster than pure consulting, more accountable than pure SaaS.

Key Products

• CAPTIS — AI-powered authoring platform purpose-built for EU MDR/IVDR clinical evaluation reports (CERs), PMS docs and literature reviews; centralized repository for sources, templates, references.
• CAPTIS Copilot — Generative-AI assistant (powered by OpenAI) layered on CAPTIS that drafts and updates compliance documents for device and diagnostic manufacturers.
• Dossplorer™ — eCTD viewer for navigating regulatory submissions
• Dosscriber™ — Automated regulatory document templates

Services

• Regulatory medical writing (CER, CSR, IB, protocols)
• CMC technical authoring (IND/IMPD, MAA/BLA, variations)
• Regulatory affairs consulting and submission management
• Clinical evaluation and post-market surveillance for MedTech/IVD

Target Customers

Pharma, medical device and IVD manufacturers (mid-size through enterprise) needing outsourced regulatory writing and EU MDR/IVDR compliance

Notable Positioning

One of the few competitors with a purpose-built AI platform (CAPTIS) for EU MDR/IVDR CERs, bundled with a large in-house medical-writing service team.

Strategy

Enterprise content and information management platform (CARA) used by 8 of the 10 largest life sciences companies (per generiscorp.com) to unify RIM, regulatory submissions, quality, safety and clinical content on a single repository. GTM thesis: replace Documentum/Veeva-style silos with one configurable platform that publishing partners (LORENZ, EXTEDO) plug into.

Key Products

• CARA Life Sciences Platform — Unified content + data platform covering RIM, regulatory submissions, dossier/submission planning, archive, labelling, IDMP and reporting; 21 CFR Part 11, GxP, HIPAA, GDPR compliant.
• CARA RIM — Regulatory information management module managing product registrations, applications, events, commitments and health authority interactions.
• CARA Submission Documents — Authoring, review, approval and integrated publishing of CTD submission components, with traceability to source content.
• CARA Quality / Safety / Clinical apps — Extensions on the same platform for QMS, pharmacovigilance, clinical trial management, medical affairs and CMC content.

Services

• Platform implementation and configuration
• Migration from legacy Documentum / SharePoint repositories

Target Customers

Top-20 and mid-size global pharma, biotech and medical device enterprises needing unified RIM/regulatory/quality content management

Notable Positioning

Foundational content/RIM backbone — not an AI authoring tool — that publishing partners (EXTEDO, LORENZ) and 8 of the 10 largest life sciences companies rely on as the system of record beneath their eCTD workflows.